Detalles de la búsqueda
1.
Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders.
Acta Neuropsychiatr
; 36(1): 17-28, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37114460
2.
Quantitative proteomics of tau and Aß in detergent fractions from Alzheimer's disease brains.
J Neurochem
; 164(4): 529-552, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36271678
3.
Cerebrospinal fluid neurofilament light and cerebral atrophy in younger-onset dementia and primary psychiatric disorders.
Intern Med J
; 53(9): 1564-1569, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36314730
4.
Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings.
Alzheimers Dement
; 18(11): 2218-2233, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35102694
5.
Retraction Notice to: Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders.
Mol Ther
; 32(6): 2034, 2024 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38608700
6.
Retraction Notice to: Corrigendum to "Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders".
Mol Ther
; 32(6): 2035, 2024 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38608701
7.
A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?
Aust N Z J Psychiatry
; 54(1): 57-67, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31220922
8.
Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders.
Mol Ther
; 24(4): 746-58, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26700614
9.
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression.
Mov Disord
; 31(10): 1535-1542, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27548849
10.
Cerebrospinal fluid neurofilament light chain is elevated in Niemann-Pick type C compared to psychiatric disorders and healthy controls and may be a marker of treatment response.
Aust N Z J Psychiatry
; 54(6): 648-649, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31823653
11.
Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease.
Mov Disord
; 29(8): 1019-27, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24436092
12.
Alzheimer's disease biomarker utilization at first referral enhances differential diagnostic precision with simultaneous exclusion of Creutzfeldt-Jakob disease.
Alzheimers Dement (Amst)
; 16(1): e12548, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38352040
13.
Diagnostic performance of CSF biomarkers in a well-characterized Australian cohort of sporadic Creutzfeldt-Jakob disease.
Front Neurol
; 14: 1072952, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36846121
14.
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias.
Mov Disord
; 26(8): 1428-35, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21469206
15.
Citrullination of Amyloid-ß Peptides in Alzheimer's Disease.
ACS Chem Neurosci
; 12(19): 3719-3732, 2021 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34519476
16.
Plant poisoning leads to alpha-synucleinopathy and neuromelanopathy in kangaroos.
Sci Rep
; 9(1): 16546, 2019 11 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31723225
17.
CSF Tau supplements 14-3-3 protein detection for sporadic Creutzfeldt-Jakob disease diagnosis while transitioning to next generation diagnostics.
J Clin Neurosci
; 50: 292-293, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29422367
18.
Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.
J Alzheimers Dis
; 61(1): 169-183, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29171991
19.
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
Mol Neurodegener
; 11: 7, 2016 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26782965
20.
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-ß Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
J Alzheimers Dis
; 48(1): 175-87, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26401938